HeartSciences (HSCS) Other Working Capital Changes (2021 - 2026)
HeartSciences (HSCS) posted quarterly Other Working Capital Changes of -$31317.0 for Q2 2026, down 16.79% year-on-year from -$37637.7 in Q2 2025, and down 6.15% on a QoQ basis from -$29503.0 in Q4 2025.
HeartSciences (HSCS) Other Working Capital Changes (2021 - 2026) Analysis & Trends
HeartSciences (HSCS) has reported Other Working Capital Changes for 4 consecutive years, with -$31317.0 the latest figure, recorded in Q2 2026.
- Quarterly Other Working Capital Changes fell 16.79% year-over-year to -$31317.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$115936.0 (down 13.34% YoY) and the FY2026 annual result came in at -$119518.0, down 16.84% from the prior year.
- Other Working Capital Changes fell to -$31317.0 in Q2 2026 per HSCS's latest filing, from -$29503.0 in the prior quarter.
- Over the last five years, Other Working Capital Changes for HSCS reached as high as $97746.0 in Q3 2025 and fell as low as -$201244.0 in Q4 2023.
- A 5-year average of -$64399.8 and a median of -$73520.0 in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2024 — Other Working Capital Changes plunged 1414.33% — and 2026, when it decreased 16.79%.
- Year by year, Other Working Capital Changes stood at -$1668.0 in 2023, then tumbled by 1414.33% to -$25259.0 in 2024, then retreated by 16.8% to -$29503.0 in 2025, then declined by 6.15% to -$31317.0 in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$31317.0, -$29503.0, and -$28302.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | HeartSciences | 2.29 Mn | -1.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -98,875.00 |
| Apr 30, 2026 | -98,875.00 |
| Apr 30, 2026 | -98,875.00 |
| Oct 31, 2025 | 20,569.00 |
| Oct 31, 2025 | 20,569.00 |
| Oct 31, 2025 | 20,569.00 |
| Jul 31, 2025 | 97,746.00 |
| Jul 31, 2025 | 97,746.00 |
| Jul 31, 2025 | 97,746.00 |
| Apr 30, 2025 | -117,193.00 |
| Apr 30, 2025 | -117,193.00 |
| Apr 30, 2025 | -117,193.00 |
| Jan 31, 2025 | -34,993.00 |
| Jan 31, 2025 | -34,993.00 |
| Jan 31, 2025 | -34,993.00 |
| Oct 31, 2024 | -165,332.00 |
| Oct 31, 2024 | -165,332.00 |
| Oct 31, 2024 | -165,332.00 |
| Jul 31, 2024 | -39,989.00 |
| Jul 31, 2024 | -39,989.00 |